These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2072670)

  • 61. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia.
    Troung DD; Rontal M; Rolnick M; Aronson AE; Mistura K
    Laryngoscope; 1991 Jun; 101(6 Pt 1):630-4. PubMed ID: 2041443
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Lateral Cricoarytenoid Release: Development of a Novel Surgical Treatment Option for Adductor Spasmodic Dysphonia in a Canine Laryngeal Model.
    Park AM; Paniello RC
    Ann Otol Rhinol Laryngol; 2016 Sep; 125(9):746-51. PubMed ID: 27257292
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dynamic aspects of phonatory control in spasmodic dysphonia.
    Ludlow CL; Connor NP
    J Speech Hear Res; 1987 Jun; 30(2):197-206. PubMed ID: 3599951
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [A probe into the relationship between spasmodic dysphonia and laryngeal paralysis].
    Yang S; He P; Lu S
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1998 Dec; 33(6):328-30. PubMed ID: 11938840
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Value of Laryngeal Electromyography in Spasmodic Dysphonia Diagnosis and Therapy.
    Yang Q; Xu W; Li Y; Cheng L
    Ann Otol Rhinol Laryngol; 2015 Jul; 124(7):579-83. PubMed ID: 25673120
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Differentiation of adductor-type spasmodic dysphonia from muscle tension dysphonia by spectral analysis.
    Rees CJ; Blalock PD; Kemp SE; Halum SL; Koufman JA
    Otolaryngol Head Neck Surg; 2007 Oct; 137(4):576-81. PubMed ID: 17903573
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Influence of Linguistic Demand on Symptom Expression in Adductor Spasmodic Dysphonia.
    Froeschke LLO
    J Voice; 2020 Sep; 34(5):807.e11-807.e21. PubMed ID: 31047737
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Botulinum toxin. A new therapeutic alternative in spastic dysphonia (laryngeal abductor dystonia)].
    Loven JO; Brøndbo K; Ganes T
    Tidsskr Nor Laegeforen; 1993 Mar; 113(7):841-3. PubMed ID: 8480289
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Indirect laryngoscopic approach for injection of botulinum toxin in spasmodic dysphonia.
    Ford CN; Bless DM; Lowery JD
    Otolaryngol Head Neck Surg; 1990 Nov; 103(5 ( Pt 1)):752-8. PubMed ID: 2126097
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Stimuli phrases of adductor spasmodic dysphonia phonatory break in mandarin Chinese].
    Ge P; Ren Q; Chen Z; Cheng Q; Sheng X; Wang L; Chen S; Zhang S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Dec; 29(24):2126-8. PubMed ID: 27093810
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Neurectomy and Myomectomy for Treatment of Spasmodic Dysphonia.
    Ryan W; Alnouri G; Sataloff RT
    J Voice; 2024 Jan; 38(1):239-242. PubMed ID: 35738960
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Symptom improvement of spastic dysphonia in response to phonatory tasks.
    Bloch CS; Hirano M; Gould WJ
    Ann Otol Rhinol Laryngol; 1985; 94(1 Pt 1):51-4. PubMed ID: 3970505
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Bilateral Vocal Fold Medialization: A Treatment for Abductor Spasmodic Dysphonia.
    Dewan K; Berke GS
    J Voice; 2019 Jan; 33(1):45-48. PubMed ID: 29132808
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dysphonia severity degree and phonation onset latency in laryngeal adductor dystonia.
    De Biase NG; Korn GP; Lorenzon P; Padovani M; Moraes M; Madazio G; Vilanova LC
    J Voice; 2010 Jul; 24(4):406-9. PubMed ID: 19766443
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Procedures for the selection of spastic dysphonia patients for recurrent laryngeal nerve section.
    Ludlow CL; Naunton RF; Bassich CJ
    Otolaryngol Head Neck Surg; 1984 Feb; 92(1):24-31. PubMed ID: 6422412
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Function of the posterior cricoarytenoid muscle in phonation: in vivo laryngeal model.
    Choi HS; Berke GS; Ye M; Kreiman J
    Otolaryngol Head Neck Surg; 1993 Dec; 109(6):1043-51. PubMed ID: 8265188
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Abnormalities in long latency responses to superior laryngeal nerve stimulation in adductor spasmodic dysphonia.
    Ludlow CL; Schulz GM; Yamashita T; Deleyiannis FW
    Ann Otol Rhinol Laryngol; 1995 Dec; 104(12):928-35. PubMed ID: 7492063
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Histology of nerves and muscles in adductor spasmodic dysphonia.
    Chhetri DK; Blumin JH; Vinters HV; Berke GS
    Ann Otol Rhinol Laryngol; 2003 Apr; 112(4):334-41. PubMed ID: 12731628
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Abductor paralysis after botox injection for adductor spasmodic dysphonia.
    Venkatesan NN; Johns MM; Hapner ER; DelGaudio JM
    Laryngoscope; 2010 Jun; 120(6):1177-80. PubMed ID: 20513036
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Central auditory evaluation of patients with spasmodic dysphonia.
    Middleton ML; Wilson KM; Keith RW
    Ear Nose Throat J; 1997 Oct; 76(10):710-5. PubMed ID: 9345814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.